Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab, a recombinant humanized monoclonal antibody targeting the IgE molecule, is the first biologic approved for moderate-to-severe allergic asthmatics, who remain uncontrolled despite high dose inhaled ...
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Manali Mukherjee, Melanie Kjarsgaard, Katherine Radford, Chynna Huang, Richard Leigh, Delbert R. Dorscheid, Catherine Lemiere, Louis-Philippe Boulet, Susan Waserman, James Martin and Parameswaran Nair Tags: Letter to the editor Source Type: research